RenovoRx today said it received FDA 510(k) clearance for its RenovoCath delivery system.
Los Altos, California-based RenovoRx designed the RenovoCath system as the device component for its RenovoGem chemotherapy drug. The combined drug/device RenovoTAMP trans-arterial micro-perfusion therapy is a dual-balloon infusion catheter that delivers chemotherapy directly to tumors through the arteries.
Get the full story on our sister site, Medical Tubing + Extrusion.